Firm News: Drugs & Devices: Page 15

On November 3, 2014, a global settlement program involving Stryker’s Rejuvenate and ABGII modular hip implants was executed before and announced by Superior Court Judge Brian R. Martinotti in Bergen County, New Jersey. The settlement was finalized after four months of negotiations before retired United States Magistrate Judge Diane Welsh of JAMS in Philadelphia. Stryker…

A devastating new study published in a leading medical journal reaffirms the growing body of literature that suggests power morcellators pose a cancer-spreading threat much worse than previously recognized. Appearing in the authoritative Journal of the American Medical Association, the study paints use of power morcellators as flatly ill-advised, as the authors found the likelihood…

Weitz & Luxenberg has launched an investigation of a device that may spread cancer in some surgical patients. Laparoscopic power morcellators, electric tools inserted into the abdomen to remove uterine fibroids and perform hysterectomies, appear to be spreading concealed sarcomas. A set of spinning blades used to cut tissue can accidentally stir up tumor cells,…

Thousands of patients whose hip implants failed and were removed prior to August 31, 2013 and who enrolled in the $2.5 billion settlement will begin to receive their settlement payments. Late last week, DePuy and its parent company Johnson & Johnson agreed to waive its ”walk-away rights” and are proceeding to fund the six-figure settlements…

A Louisiana jury has awarded $9 billion to a New York man who developed bladder cancer after taking Actos. The verdict, issued Monday night, orders Takeda Pharmaceuticals to pay $6 billion in punitive damages, and Eli Lilly to pay $3 billion. Plaintiff Terrence Allen, a New York resident, was diagnosed with bladder cancer in 2011…